Entries by

EAACI 2015 Award

The work presented in the Congress of the EAACI 2015 (European Academy of Allergy and Clinical Immunology) (Barcelona, Spain) within the session JMA Junior Members and Affiliates by Jose F. Cantillo


Report in the section INNOVATORS from El Mundo, one of the top Spanish newspapers. The report highlights the new generation of vaccines targeting dendritic cells developed by INMUNOTEK SL in an interview with the CEO-President of INMUNOTEK Dr. Jose Luis Subiza

Mucosal adjuvants

A review on recent patents in mucosal adjuvants has been published in the journal Recent Patents on Inflammation & Allergy Drug Discovery. Mucosal surfaces are the major entrance for infectious pathogens and therefore mucosal immune responses serve as a first line of defence


The ICEX (Instituto de Comercio Exterior) an agency from the Ministry of Economy and Competitiveness has interviewed Dr. Jose Luis Subiza, CEO-President of INMUNOTEK SL as a model company for its growth strategy